• Return to Headlines

Shares of CTMX Down 18.8% Since Downtrend Call on Shares

By James Quinn

SmarTrend identified a Downtrend for Cytomx Therapeut (NASDAQ:CTMX) on February 27th, 2019 at $12.97. In approximately 2 months, Cytomx Therapeut has returned 18.78% as of today's recent price of $10.53.

In the past 52 weeks, Cytomx Therapeut share prices have been bracketed by a low of $9.38 and a high of $30.73 and are now at $10.46, 12% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 1.1% while the 50-day MA has declined 3.1%.

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops a novel class of investigational antibody therapeutics based on its Probody technology platform for the treatment of cancer.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Cytomx Therapeut.

Log in and add Cytomx Therapeut (CTMX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights cytomx therapeut

Ticker(s): CTMX